Therapeutic Research

No data available.
Please log in to see this content.
You have no subscription access to this content.
The full text of this article is not currently available.
1. 高脂血症を合併した2型糖尿病性腎症におけるHMG−CoA還元酵素阻害薬シンバスタチンの腎保護効果を検討する多施設共同研究(MIDN Study): 中間解析報告  (研究統括医師(腎と脂質研究会代表世話人))
Rent this article for

Full text loading...


Data & Media loading...

This is a required field
Please enter a valid email address

Oops! This section, does not exist...

Use the links on this page to find existing content.

Sign in or Register
Please sign in or register to use this feature
Complete your profile
Please complete your profile to use this feature